Abstract CT052: Clinical safety and efficacy study of TruUCAR™ GC027: The first-in-human, universal CAR-T therapy for adult relapsed/refractory T-cell acute lymphoblastic leukemia (r/r T-ALL)Xinxin Wang, Xi Zhang, Le Luo et al.|Cancer Research|2020Cited by 30
Abstract LB147: Updates on clinical safety and efficacy result of GC027, the first-in-human, “Off-the-Shelf” CD7 CAR-T stand-alone therapy for adult patients with relapsed/refractory T-cell lymphoblastic leukemia (r/r T-ALL)Shiqi Li, Xi Zhang, Lei Gao et al.|Cancer Research|2021Cited by 4
Tankyrase-mediated ADP-ribosylation is a novel regulator of TNF-induced deathLin Liu, John Silke|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 0